Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2,420
Closed -$274K 1029
2024
Q2
$274K Sell
2,420
-2,893
-54% -$366K 0.02% 692
2024
Q1
$737K Buy
5,313
+2,813
+113% +$354K 0.04% 411
2023
Q4
$310K Sell
2,500
-402
-14% -$41.1K 0.06% 343
2023
Q3
$271K Buy
+2,902
New +$327K 0.05% 377

Other funds holding DXCM

PFG Investments's DXCM Position: Q3 2024 in Review

PFG Investments sold out of DexCom (DXCM) in Q3 2024, closing a stake of 2,420 shares — an estimated $274K sold.

PFG Investments first reported a position in DXCM in Q3 2023 and held it in 4 quarters. The position peaked at $737K in Q1 2024. 889 funds tracked by Wall St. Rank hold DXCM as of Q3 2024.

  • PFG Investments reported no remaining DexCom position as of Q3 2024 after selling out during the quarter.
  • PFG Investments sold 2,420 DexCom shares in Q3 2024, an estimated $274K.
  • PFG Investments first reported a position in DexCom in Q3 2023 and held it in 4 quarters.
  • PFG Investments's DexCom position peaked at $737K in Q1 2024.
  • 889 funds tracked by Wall St. Rank held DexCom as of Q3 2024.

Based on PFG Investments's 13F filing for Q3 2024, filed 24 Oct 2024.